hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia
retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer
significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized..
paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: results from nsabp b-28
addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase ii trial
combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer
2-(18f)-fluoro-2-deoxy-d-glucose positron emission tomography detects clinical relevant adenomas of the colon: a prospective study
the metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer
successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in ..
nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study
childhood cancer survival trends in europe: a eurocare working group study
randomized phase iii intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-sta..
phase iii study of the eastern cooperative oncology group (ecog 2597): induction chemotherapy followed by either standard thoracic radiotherapy or hyperfractionated..
gastric mucosa-associated lymphoid tissue lymphoma detected by clonotypic polymerase chain reaction despite continuous pathologic remission induced by involved-fiel..
expression of bcl-2 in classical hodgkin's lymphoma: an independent predictor of poor outcome
evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, a..
impact of three courses of intensified chop prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-r..
analysis of treatment practices for elderly cancer patients in ontario, canada
impact of managed care on cancer trial enrollment
evaluation of a 7-day continuous intravenous infusion of decitabine: inhibition of promoter-specific and global genomic dna methylation
pharmacokinetics of 5-azacitidine administered with phenylbutyrate in patients with refractory solid tumors or hematologic malignancies
phase i and pharmacokinetic study of ms-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma
phase i study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer
protein expression of a triad of frequently methylated genes, p73, p57kip2, and p15, has prognostic value in adult acute lymphocytic leukemia independently of its m..
phase ii study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate
inactivation of the lamin a/c gene by cpg island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse larg..
cyclin d1 in breast cancer pathogenesis
adult-type soft tissue sarcomas in pediatric-age patients: experience at the istituto nazionale tumori in milan
phase ii trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-..
improved response in high-risk neuroblastoma with protracted topotecan administration using a pharmacokinetically guided dosing approach
impact of latent epstein-barr virus infection on outcome in children and adolescents with hodgkin's lymphoma
the departments of pediatrics and hematopathology, german lymph node registry, university of kiel, kiel
early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia
phase ii study of g3139, a bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients
abl mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of p..
phase iii randomized multicenter study of a humanized anti-cd33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in pati..
use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy
randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients w..
achieving optimal outcomes after radical prostatectomy
long-term results of the r-chop study in the treatment of elderly patients with diffuse large b-cell lymphoma: a study by the groupe d'etude des lymphomes de l'adulte
phase i pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies
phase i study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of ptk787/zk 222584 administered twice daily in patients with advanced cancer
randomized phase ii/iii trial of interferon alfa-2a with and without 13-cis-retinoic acid in patients with progressive metastatic renal cell carcinoma: the european..
risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: correlation with doses of epirubicin and cyclo..
chemotherapy for breast cancer during pregnancy: an 18-year experience from five london teaching hospitals